Samsung Pharm (001360) — Cash Flow Reinvestment Rate
Samsung Pharm (001360) has a Cash Flow Reinvestment Rate of 0.48x as of June 2022, reinvesting ₩766.26 Million (capex ₩638.30 Million plus investments ₩-127.95 Million) from operating cash flow of ₩1.59 Billion. Explore Samsung Pharm (001360) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samsung Pharm Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Samsung Pharm across 1 annual periods. Also explore how large is Samsung Pharm's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Samsung Pharm (2017–2017)
Year-by-year capital reinvestment analysis for Samsung Pharm. For live market cap and broader valuation context, see Samsung Pharm market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 1.26x | ₩6.51 Billion | ₩5.15 Billion | ₩6.11 Billion | — |